Ερευνητικό υλικό ΕΚΠΑ

Low-Dose Cotrimoxazole Administered in Hematopoietic Stem Cell Transplant Recipients as Prophylaxis for Pneumocystis jirovecii Pneumonia Is Effective in Prevention of Infection due to Nocardia

Αγγλικά

Δεν υπάρχει περίληψη

2019

Gkirkas, K.
Stamouli, M.
Thomopoulos, T.
Kontos, F.
Kavatha, D.
Siafakas, N.
Karagiannidou, A.
Pournaras, S.
Antoniadou, A.
Tsirigotis, P.

Biology of Blood and Marrow Transplantation

HANLEY & BELFUS-ELSEVIER INC

25

9

e298-e299

atovaquone; corticosteroid; cotrimoxazole; pentamidine; cotrimoxazole, graft recipient; graft versus host reaction; hematopoietic stem cell transplantation; human; human tissue; Letter; low drug dose; major clinical study; Nocardia; nocardiosis; Pneumocystis pneumonia; prophylaxis; retrospective study; allograft; female; hematopoietic stem cell transplantation; male; Nocardia; nocardiosis; Pneumocystis carinii; Pneumocystis pneumonia, Allografts; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Nocardia; Nocardia Infections; Pneumocystis carinii; Pneumonia, Pneumocystis; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination

https://doi.org/10.1016/j.bbmt.2019.07.018

10.1016/j.bbmt.2019.07.018

https://pergamos.lib.uoa.gr/uoa/dl/object/3105683